GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (FRA:VB0) » Definitions » Short-Term Debt

Viva Biotech Holdings (FRA:VB0) Short-Term Debt : €121.9 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Short-Term Debt?

Viva Biotech Holdings's Short-Term Debt for the quarter that ended in Dec. 2023 was €121.9 Mil.

Viva Biotech Holdings's quarterly Short-Term Debt increased from Dec. 2022 (€259.2 Mil) to Jun. 2023 (€294.1 Mil) but then declined from Jun. 2023 (€294.1 Mil) to Dec. 2023 (€121.9 Mil).

Viva Biotech Holdings's annual Short-Term Debt increased from Dec. 2021 (€32.4 Mil) to Dec. 2022 (€259.2 Mil) but then declined from Dec. 2022 (€259.2 Mil) to Dec. 2023 (€121.9 Mil).


Viva Biotech Holdings Short-Term Debt Historical Data

The historical data trend for Viva Biotech Holdings's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Short-Term Debt Chart

Viva Biotech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial 0.07 19.55 32.38 259.15 121.94

Viva Biotech Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.51 259.15 294.11 121.94 -

Viva Biotech Holdings Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Viva Biotech Holdings Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Viva Biotech Holdings Business Description

Traded in Other Exchanges
Address
735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.

Viva Biotech Holdings Headlines

No Headlines